Sunshine Biopharma (SBFM) Non Operating Income (2012 - 2026)
Sunshine Biopharma's (SBFM) quarterly Non Operating Income came in at $151728.0 in Q1 2026, up 100.12% YoY from $75818.0 in Q1 2025, and up 164.07% on a QoQ basis from $57458.0 in Q4 2025.
Sunshine Biopharma (SBFM) Non Operating Income (2012 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 14 years of Non Operating Income data on file, last reported at $151728.0 in Q1 2026.
- Quarterly Non Operating Income rose 100.12% year-over-year to $151728.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $349196.0 (down 8.26% YoY) and the FY2025 annual result came in at $273286.0, down 38.33% from the prior year.
- Non Operating Income climbed to $151728.0 in Q1 2026, from $57458.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $430285.0 in Q2 2024 to a low of -$249227.0 in Q4 2024.
- A 5-year average of $118075.3 and a median of $123767.0 in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2023 — Non Operating Income soared 1442.82% — and 2024, when it sank 258.28%.
- Tracing SBFM's Non Operating Income over 5 years: stood at $84599.0 in 2022, then surged by 86.13% to $157464.0 in 2023, then slumped by 258.28% to -$249227.0 in 2024, then soared by 123.05% to $57458.0 in 2025, then surged by 164.07% to $151728.0 in 2026.
- The last three Non Operating Income figures came in at $151728.0 (Q1 2026), $57458.0 (Q4 2025), and $65355.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sunshine Biopharma | 1.53 Mn | -12.22 Mn | 2.43 Mn | 48,810.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48,810.00 |
| Mar 31, 2026 | 151,728.00 |
| Dec 31, 2025 | 57,458.00 |
| Sep 30, 2025 | 65,355.00 |
| Jun 30, 2025 | 74,655.00 |
| Mar 31, 2025 | 75,818.00 |
| Dec 31, 2024 | -249,227.00 |
| Sep 30, 2024 | 123,767.00 |
| Jun 30, 2024 | 430,285.00 |
| Mar 31, 2024 | 89,141.00 |
| Dec 31, 2023 | 157,464.00 |
| Sep 30, 2023 | 168,944.00 |
| Jun 30, 2023 | 199,457.00 |
| Mar 31, 2023 | 172,821.00 |
| Dec 31, 2022 | 84,599.00 |
| Sep 30, 2022 | 260,961.00 |
| Jun 30, 2022 | 156,924.00 |
| Mar 31, 2022 | -12,870.00 |
| Dec 31, 2021 | 946,747.00 |
| Sep 30, 2021 | -3.54 Mn |